XTT-colorimetric assay as a marker of viability in cryoprocessed cardiac valve

Jen Her Lu, Yung Tsung Chiu, Hsing Wen Sung, Betau Hwang, Chuh Khiun Chong, Shih Ping Chen, Simon J. Mao, Pin Zen Yang, Yen Chang

研究成果: 雜誌貢獻文章同行評審

9 引文 斯高帕斯(Scopus)


This study sought to evaluate the use of tetrazolium salt XTT reduction as an indicator of valvular viability in a cryoprocessed porcine cardiac homograft model. The XTT tetrazolium assays was based on the metabolic reduction of Sodium 3'-[l-(phenylamino-carbonyl)-3,4-Tetrazolium]-bis(4-methoxy-6-nitro) benzene sulfonic acid hydrate. The relationship between XTT reduction and: (1) leaflet tissue with various weight (n=24); (2) morphometric evaluation (n=30); (3) cadaveric ischemic intervals (n=30); (4) freeze-thawing (n=30) has been studied. The measurement of XTT reduction were significantly correlated with the weight of cardiac leaflets, in the range of 30 to 180mg (y=0.015x-0.063; r=0.99). Compared to morphometry of valvular damage, the reduction of mitochondrial enyzmatic activity in cardiac leaflets was correlated with matrix cells without irreversible damage (r=0.89, P<0.005). The depletion of XTT reduction occurred dependent of ischemic time intervals. In general, freeze-thawing reduced more than 20% activity of mitochondrial dehydrogenase. We concluded that XTT tetrazolium assay is highly sensitive to determine valvular injury. The study demonstrated its potential for testing of cryopreserved cardiac valve.

頁(從 - 到)1189-1194
期刊Journal of Molecular and Cellular Cardiology
出版狀態已發佈 - 4月 1997

ASJC Scopus subject areas

  • 分子生物學
  • 心臟病學與心血管醫學


深入研究「XTT-colorimetric assay as a marker of viability in cryoprocessed cardiac valve」主題。共同形成了獨特的指紋。